Today: 29 April 2026
CoreWeave stock price: Nvidia’s $2 billion buy puts CRWV back in play before the open
27 January 2026
1 min read

CoreWeave stock price: Nvidia’s $2 billion buy puts CRWV back in play before the open

New York, Jan 27, 2026, 05:06 ET — Premarket

CoreWeave Inc (CRWV) shares climbed 5.7% to $98.31 on Monday following Nvidia’s announcement of a $2 billion investment in the AI cloud company, at a price of $87.20 per share. The deal will add roughly 23 million shares to Nvidia’s stake, making it CoreWeave’s second-largest shareholder. Pre-market trading saw the stock jump around 9% after the news broke. CoreWeave said it plans to use the funds for expanding its data centers, boosting research, and growing its workforce—not for purchasing Nvidia processors.

The deal is crucial because CoreWeave is deep into its costly expansion phase. The company operates data centers packed with graphics processing units, or GPUs — the chips powering AI model training and deployment — which it leases out. CoreWeave went public in March 2025 and has long been a dedicated Nvidia customer.

Nvidia and CoreWeave are pushing an accelerated rollout of what they call “AI factories”—data centers tailored specifically for AI workloads. Their target: more than 5 gigawatts of AI factory capacity by 2030. CoreWeave will integrate Nvidia’s CPU and storage platforms, including Rubin and Vera CPUs plus BlueField storage, across several Nvidia system generations. “AI is entering its next frontier,” Nvidia CEO Jensen Huang said, dubbing this effort “the largest infrastructure buildout in human history.” CoreWeave CEO Michael Intrator added that the expanded partnership highlights “the strength of demand” from their customer base. CoreWeave

A filing with the U.S. Securities and Exchange Commission revealed CoreWeave sold 22,935,780 Class A shares to Nvidia in a private placement—a direct sale to one buyer, not the open market. The document states the deal was done under a securities purchase agreement and ties the investment to a collaboration framework between the two companies.

The shift comes as investors prepare for a packed week in rate-sensitive tech. Wall Street awaits earnings from Apple (AAPL), Meta (META), Microsoft (MSFT) and Tesla (TSLA), seeking clues that hefty AI investments are starting to pay off.

But that same spending also poses a risk. CoreWeave took a hit last year as investors scrutinized how the data-center boom is being financed. “Neocloud” firms without the deep pockets of hyperscalers like Microsoft and Alphabet (GOOGL) faced the toughest questions. For CoreWeave, the Nvidia connection is a double-edged sword: it can bring steady funding but also shines a spotlight on who’s really paying for the AI buildout. Investopedia

Before Tuesday’s open, traders will eye if CRWV stays above the $87.20 mark Nvidia paid. The big question: will the early jump lure more buyers or trigger swift profit-taking? New updates on stake shifts or funding could also shake the stock.

On Wednesday, Jan. 28, the Federal Reserve wraps up its meeting with a policy statement, followed by Chair Jerome Powell’s press briefing. This rate guidance has been shaping demand for fast-growing AI stocks, and CoreWeave is once again caught in that flow.

Stock Market Today

  • Tuya (TUYA) Stock Analysis: Fair Pricing Amid Recent Pullback and Strong Long-Term Gains
    April 29, 2026, 12:05 PM EDT. Tuya (NYSE:TUYA) shares closed at $2.28, down 3.0% in one day and 6.2% over seven days, contrasting with a 3-year total shareholder return of 28.7%. The company reported $321.8 million in annual revenue and $57.9 million net income. Trading at a price-to-earnings (P/E) ratio of 24.1x, Tuya's valuation is slightly above its fair value estimate of 23.5x and peers' average of 21.7x, but below the broader U.S. Software industry average of 30.4x. This reflects investor confidence in its profitability and growth prospects, with earnings expected to grow nearly 10% annually. Risks include dependence on Chinese market demand and relatively rich valuation compared to peers. The stock trades just 0.9% below its intrinsic value according to discounted cash flow (DCF) estimates, suggesting near fair pricing.

Latest article

Mastercard Stock Jumps Before Earnings as Visa’s Big Beat Sends a Fresh Signal

Mastercard Stock Jumps Before Earnings as Visa’s Big Beat Sends a Fresh Signal

29 April 2026
Mastercard shares climbed 3.8% to $526.90 Wednesday after Visa beat profit estimates and raised its outlook, sending Visa shares up 8.7%. Mastercard reports first-quarter results Thursday. The company expanded its Start Path program this week to focus on business payments, with fintech Glass joining to work on public-sector procurement. Mastercard does not lend or issue cards, earning mainly from transaction fees.
GE HealthCare Technologies Inc. Stock Sinks as Tariffs and Chip Costs Force Profit Cut

GE HealthCare Technologies Inc. Stock Sinks as Tariffs and Chip Costs Force Profit Cut

29 April 2026
GE HealthCare cut its 2026 profit forecast Wednesday, citing higher chip, oil, and freight costs, as well as tariffs and a supplier issue. Shares fell nearly 13% to $59.75. First-quarter revenue rose 7.4% to $5.13 billion, but net income dropped to $389 million from $564 million a year earlier. The company also announced a reorganization, merging its Imaging and Advanced Visualization units.
Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

29 April 2026
The U.S. Commerce Department ordered Applied Materials, Lam Research, and KLA to halt some chip-tool shipments to China’s Hua Hong, Reuters reported. The move targets shipments linked to facilities believed capable of advanced chip production. Applied reported $2.10 billion in China revenue last quarter, or 30% of its total. Shares in Applied, Lam, and KLA traded lower after the news.
GSK share price rises after EU clears Arexvy for adults 18+ as earnings near
Previous Story

GSK share price rises after EU clears Arexvy for adults 18+ as earnings near

CVS stock slides before the bell as Medicare Advantage rate shock hits insurers
Next Story

CVS stock slides before the bell as Medicare Advantage rate shock hits insurers

Go toTop